NASDAQ:PACB

Pacific Biosciences Of California Stock News

etoro logo Buy PACB
*Your capital is at risk
$1.15
-0.0350 (-2.95%)
At Close: Aug 10, 2026
LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate...
Serb-led entity has been urged to withdraw new decree banning the spread of panic – as journalists’ union complains of repeated moves in the country to censor information about COVID-19 under the
The "Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Rupee Edges Lower To 75.85 Against Dollar

06:21am, Wednesday, 08'th Apr 2020
The rupee opened weak at 75.83 at the interbank forex market and then fell further to 75.85, down 21 paise over its last close.

Pacific Biosciences Still Can't Catch A Break

02:34pm, Tuesday, 07'th Apr 2020
An adverse ruling in patent litigation against Oxford Nanopore continues a string of negative developments for this life sciences company. Fourth quarter Sequel
Jane Street Group LLC raised its position in Pacific Biosciences of California (NASDAQ:PACB) by 78.5% during the fourth quarter, according to the company in its most recent disclosure with the Securit
The "Global RNA Sequencing Market: Focus on Product, Technology, Workflow, End User, Application, Region, and Competitive Landscape - Analysis and Forecast, 2019-2028" report has been added to Researc
Dublin, April 06, 2020 -- The "Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to.
This gene-sequencing pioneer hasn't been immune to the coronavirus' effects. But do Illumina's long-term prospects outweigh any short-term pain?
Man Group plc decreased its stake in Pacific Biosciences of California (NASDAQ:PACB) by 39.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exc
Pacific Biosciences of California (NASDAQ:PACB) dropped 8.3% on Friday . The company traded as low as $2.54 and last traded at $2.65, approximately 1,468,402 shares traded hands during mid-day trading
Dublin, April 02, 2020 -- The "Global RNA Sequencing Market: Focus on Product, Technology, Workflow, End User, Application, Region, and Competitive Landscape - Analysis and.
Equities analysts expect Pacific Biosciences of California (NASDAQ:PACB) to report sales of $21.37 million for the current quarter, according to Zacks. Three analysts have made estimates for Pacific B
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE